Gabapentin price December 2025 and outlook (see chart below)
- India:US$23.33/KG, -0.2% down
Business Analytiq assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, or timeliness.
NEED A QUICK DOWNLOAD?
ACCESS TO OUR FULL DATABASE IS US$399/YEAR, WITH A 30-DAY $50 TRIAL
GET THAT DOWNLOAD IN 3 MINUTES!
BusinessAnalytiq provides a database of hundreds of market & price trend data, as well as online tools to set up benchmarks and leading indicators.
Gabapentin price index
This post is a summary of the Gabapentin price developments. The price developments of Gabapentin are expressed in US$ prices converted FX rates applicable at the time when the price was valid. Gabapentin price index developments are calculated from multiple separate sources of data to ensure statistical accuracy.
The outlook for Gabapentin prices is generated from different inputs including:
- Very recent price developments of immediate cost drivers of Gabapentin prices
- Recent price developments of underlying feedstocks which drive the price of Gabapentin
- Market futures for both cost drives and feedstocks of Gabapentin prices
- Adjustment of current supply/demand imbalances in the Gabapentin market
- Longer term trends in likely demand conditions
What is Gabapentin and what is it used for
Gabapentin is a gabapentinoid anticonvulsant medication originally developed to treat epilepsy; it is now commonly used to treat neuropathic (nerve) pain such as postherpetic neuralgia and is prescribed off-label for a variety of pain, sleep, and anxiety-related conditions. It works by binding to the α2δ subunit of voltage-gated calcium channels and reducing release of excitatory neurotransmitters, which calms overactive neural signaling.
How is Gabapentin
Gabapentin is available as oral capsules, tablets and an oral solution and is taken by mouth (typically with a gradual dose titration). Dosing must be adjusted for kidney function; common side effects include drowsiness and dizziness, and rare but serious risks (for example respiratory depression or mood changes) are described in product labeling. Clinicians choose duration and dose based on the condition being treated and patient response.
How large is the global market for Gabapentin
Market estimates vary by source, but recent market research places the global gabapentin market in the low-to-mid single-digit billions of US dollars: examples include an estimated USD ~2.25–2.9 billion market value around 2024–2025, with forecasts projecting steady growth (CAGRs in the ~5–6% range) over the next decade.
Where is it produced
Gabapentin is manufactured worldwide by many generic drug and active pharmaceutical ingredient (API) producers; major producers and contract manufacturers include large generic pharmaceutical firms and API suppliers based in India and China, with finished-dose products also supplied by multinational generics companies (e.g., Teva, Aurobindo, Sun Pharma, Cipla and others) for markets such as the US and EU. API supplier listings and patent/generic registries show a broad, global manufacturing base concentrated in large generic-API hubs.